XML 37 R30.htm IDEA: XBRL DOCUMENT

Revenue and Segment Information (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Net Revenue by Organ and Country

The Company disaggregates revenue from contracts with customers related to OCS transplant by organ type and geographical area as it believes this presentation best depicts how the nature, amount, timing and uncertainty of the Company’s revenue and cash flows are affected by economic factors, as shown below (in thousands):


		Three Months Ended March 31,
		2025				2024
OCS transplant revenue by country by organ(1)(2):
United States
Lung total revenue		$	3,636			$	4,706
Heart total revenue			26,266				20,224
Liver total revenue			108,715				66,926
Total United States OCS transplant revenue			138,617				91,856
All other countries
Lung revenue			375				960
Heart revenue			3,550				3,131
Liver revenue			140				—
Total all other countries OCS transplant revenue			4,065				4,091
Total OCS transplant revenue		$	142,682			$	95,947

(1)

Revenue by country is categorized based on the location of the end customer. Total OCS transplant revenue includes product and service revenue.

(2)

Service revenue unrelated to OCS transplant, which was $0.9 million for each of the three months ended March 31, 2025 and 2024, is not included in this table.

Summary of Significant Segment Expenses

Significant segment expenses, as provided to the CODM, are presented below (in thousands):


		Three Months Ended March 31,
		2025				2024
Total revenue		$	143,537			$	96,850
Less:
Cost of net product revenue			16,312				14,084
Cost of service revenue			38,997				22,804
Research, development and clinical trials:
Personnel related (including stock-based compensation expense)			6,252				5,264
Laboratory supplies and research materials			4,956				2,314
Consulting and third-party services			4,173				2,007
Clinical trials costs			81				82
Facility related and other			1,698				1,713
Selling, general and administrative:
Personnel related (including stock-based compensation expense)			27,671				24,387
Professional and consultant fees			7,558				3,765
NOP support			2,406				1,962
Tradeshows and conferences			426				983
Facility related and other			5,564				5,064
Other segment items(1)			1,761				224
Net income		$	25,682			$	12,197

(1) Other segment items include interest income, interest expense, foreign currency exchange gains and losses and income taxes. See the condensed consolidated financial statements for other financial information regarding the Company’s operating segment.